MX2010010607A - Composiciones para goma de mascar que comprenden canabinoides. - Google Patents

Composiciones para goma de mascar que comprenden canabinoides.

Info

Publication number
MX2010010607A
MX2010010607A MX2010010607A MX2010010607A MX2010010607A MX 2010010607 A MX2010010607 A MX 2010010607A MX 2010010607 A MX2010010607 A MX 2010010607A MX 2010010607 A MX2010010607 A MX 2010010607A MX 2010010607 A MX2010010607 A MX 2010010607A
Authority
MX
Mexico
Prior art keywords
chewing gum
cannabinoids
gum compositions
chewing
gum composition
Prior art date
Application number
MX2010010607A
Other languages
English (en)
Inventor
Anne Van Damme Philippus
Evgeniyevich Anastassov George
Original Assignee
Stichting Sanammad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40793287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010010607(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Sanammad filed Critical Stichting Sanammad
Publication of MX2010010607A publication Critical patent/MX2010010607A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00Containers, packaging elements or packages, specially adapted for particular articles or materials
    • B65D85/70Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Composite Materials (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)

Abstract

La presente invención se relaciona con una composición para goma de mascar que comprende 0.01 hasta 15% en peso de un canabinoide o un derivado del mismo, con base en el peso total de la composición para goma de mascar, y con una goma de mascar y los empaques de envoltura transparente que comprenden las gomas de mascar.
MX2010010607A 2008-03-26 2009-03-26 Composiciones para goma de mascar que comprenden canabinoides. MX2010010607A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3945108P 2008-03-26 2008-03-26
PCT/NL2009/050149 WO2009120080A1 (en) 2008-03-26 2009-03-26 Chewing gum compositions comprising cannabinoids

Publications (1)

Publication Number Publication Date
MX2010010607A true MX2010010607A (es) 2011-03-29

Family

ID=40793287

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010010607A MX2010010607A (es) 2008-03-26 2009-03-26 Composiciones para goma de mascar que comprenden canabinoides.

Country Status (15)

Country Link
US (2) US9023322B2 (es)
EP (1) EP2280687B1 (es)
BR (1) BRPI0910094B1 (es)
CA (1) CA2719830C (es)
DK (1) DK2280687T3 (es)
ES (1) ES2727648T3 (es)
HR (1) HRP20190944T1 (es)
HU (1) HUE044439T2 (es)
LT (1) LT2280687T (es)
MX (1) MX2010010607A (es)
PL (1) PL2280687T3 (es)
PT (1) PT2280687T (es)
SI (1) SI2280687T1 (es)
TR (1) TR201907776T4 (es)
WO (1) WO2009120080A1 (es)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0910094B1 (pt) 2008-03-26 2021-08-10 Stichting Sanammad Composição de goma de mascar, e, blíster
GB2471523A (en) 2009-07-03 2011-01-05 Gw Pharma Ltd Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
TWI583374B (zh) 2010-03-30 2017-05-21 Gw伐瑪有限公司 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
WO2013147965A1 (en) * 2012-03-28 2013-10-03 Freeman Keith Gerald Medical compositions, methods of making and using those compositions, and kits including those compositions
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US9744128B2 (en) 2014-06-05 2017-08-29 Mastix LLC Method for manufacturing medicated chewing gum without cooling
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2527599A (en) 2014-06-27 2015-12-30 Gw Pharma Ltd Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
AU2015305215A1 (en) * 2014-08-22 2017-04-06 Medipath, Inc. Compositions and methods for cannabinoid coatings for use in drug delivery
GB2531278A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
US20160220593A1 (en) * 2015-02-02 2016-08-04 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
GB2541191A (en) 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
EP3359142B1 (en) 2015-10-07 2020-12-09 NordicCan A/S Medical chewing gum comprising cannabinoid
GB2548873B (en) 2016-03-31 2020-12-02 Gw Res Ltd Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
WO2017184584A1 (en) * 2016-04-19 2017-10-26 Ascent Pharmaceuticals, Inc. Stable packaging system for moisture and oxygen sensitive pharmaceutical dosage forms
WO2017189375A1 (en) * 2016-04-27 2017-11-02 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and nicotine
US9901607B2 (en) 2016-04-28 2018-02-27 Mark J. Silen Smokeless cannabis composition and method of manufacture
US20200268652A1 (en) * 2016-05-15 2020-08-27 Betty Hess Cannabis infused bubble gum for sub-lingual delivery of cannabinoids
US10653639B2 (en) 2016-05-16 2020-05-19 Cv Sciences, Inc. Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
EP3463287A1 (en) * 2016-05-27 2019-04-10 MedCan Pharma A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
US10765658B2 (en) * 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
PT3474844T (pt) 2016-06-28 2022-11-08 Trichomeshell Ltd Uma forma de dosagem para ser vaporizada e fumada
GB2551987A (en) 2016-07-01 2018-01-10 Gw Res Ltd Oral cannabinoid formulations
GB2551986A (en) 2016-07-01 2018-01-10 Gw Res Ltd Parenteral formulations
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation
GB2553139A (en) 2016-08-25 2018-02-28 Gw Res Ltd Use of cannabinoids in the treatment of multiple myeloma
US10278951B1 (en) 2016-09-29 2019-05-07 Jon Newland Method of treating opiate dependency using tetrahydrocannabinol extracts
EP3528804B1 (en) * 2016-10-20 2023-07-26 APIRX Pharmaceutical USA, LLC Chewing gum composition comprising cannabinoids and opioid agonists and/or antagonists
US20180147141A1 (en) * 2016-11-29 2018-05-31 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and gabapentin
GB2557921A (en) 2016-12-16 2018-07-04 Gw Res Ltd Use of cannabinoids in the treatment of angelman syndrome
GB2559774B (en) 2017-02-17 2021-09-29 Gw Res Ltd Oral cannabinoid formulations
US20190224117A1 (en) * 2017-06-14 2019-07-25 Yury Leon Shmerlis Cannabis Extract Chewing Gum
WO2018233781A1 (en) 2017-06-23 2018-12-27 Medcan Pharma A/S SACHET OF CANNABINOIDS
US10272051B2 (en) 2017-08-28 2019-04-30 Axim Biotechnologies, Inc. Method to treat atopic dermatitis
GB2569961B (en) 2018-01-03 2021-12-22 Gw Res Ltd Pharmaceutical
GB201806953D0 (en) 2018-04-27 2018-06-13 Gw Res Ltd Cannabidiol Preparations
US20200069581A1 (en) * 2018-09-04 2020-03-05 Babak Ghalili Cannabinoid and anesthetic gum and lozenge compositions and methods
US11376227B2 (en) 2018-09-04 2022-07-05 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
WO2020051055A2 (en) * 2018-09-04 2020-03-12 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
US11406593B2 (en) 2019-01-25 2022-08-09 Nordiccan A/S Cannabinoid chewing gum with high intensity sweeteners
MX2021008935A (es) * 2019-01-25 2021-08-24 Nordiccan As Goma de mascar de cannabinoide con alcoholes de azucar.
EP3914088A1 (en) 2019-01-25 2021-12-01 NordicCan A/S Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
WO2020151793A1 (en) 2019-01-25 2020-07-30 Medcan Pharma A/S Chewing gum with improved delivery of cannabinoids
US11191720B2 (en) 2019-01-25 2021-12-07 Nordiccan A/S Chewing gum with improved delivery of cannabinoids
EP3914226A1 (en) 2019-01-25 2021-12-01 NordicCan A/S Cannabinoid chewing gum with improved release of cannabinoids
US11013685B2 (en) 2019-01-25 2021-05-25 Nordiccan A/S Cannabinoid chewing gum with improved release of cannabinoids
US11166910B2 (en) 2019-01-25 2021-11-09 Nordiccan A/S Cannabinoid chewing gum with sugar alcohols
US11154496B2 (en) 2019-01-25 2021-10-26 Nordiccan A/S Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
CN113365503A (zh) * 2019-01-25 2021-09-07 诺狄更斯公司 具有高强度甜味剂的大麻素口香糖
WO2020177822A1 (en) 2019-03-01 2020-09-10 Medcan Pharma A/S Tableted chewing gum with enhanced delivery of cannabinoids
US10799450B2 (en) 2019-03-01 2020-10-13 Medcan Pharma A/S Tableted cannabinoid chewing gum with layered structure
US20200276118A1 (en) * 2019-03-01 2020-09-03 Medcan Pharma A/S Tableted cannabinoid chewing gum with improved release
EP3930695A1 (en) 2019-03-01 2022-01-05 NordicCan A/S Tableted cannabinoid chewing gum with improved release
AU2019432305B2 (en) 2019-03-01 2023-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11471405B2 (en) 2019-03-01 2022-10-18 Nordiccan A/S Tableted chewing gum with enhanced delivery of cannabinoids
ES2970150T3 (es) * 2019-03-01 2024-05-27 Nordiccan As Goma de mascar cannabinoide en comprimidos con una estructura en capas
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11253473B2 (en) 2019-03-01 2022-02-22 Nordiccan A/S Method of producing tableted cannabinoid chewing gum
MX2022003189A (es) 2019-09-16 2022-06-08 Vapor Cartridge Tech Llc Sistema de administración de fármacos con sustratos apilables.
WO2021078999A1 (en) 2019-10-25 2021-04-29 Newmark Biotech, Llc Chewing gum or lozenge composition comprising cbd
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
WO2021177942A1 (en) * 2020-03-03 2021-09-10 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
US11160757B1 (en) 2020-10-12 2021-11-02 GW Research Limited pH dependent release coated microparticle cannabinoid formulations

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187320A (en) * 1978-05-01 1980-02-05 Warner-Lambert Company Process for preparing chewing gum base using solid elastomer
DK161428C (da) * 1985-05-10 1991-12-16 Fertin Lab As Fast, oralt cariesmodvirkende middel
FR2611501B1 (fr) * 1987-03-04 1991-12-06 Corbiere Jerome Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
DK365389D0 (da) * 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
JP2002518291A (ja) * 1997-08-20 2002-06-25 フイズ テクノロジーズ リミテッド 錠剤組成物の流動性及び圧縮性の改善方法
AU2001261744A1 (en) 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US20040028772A1 (en) * 2000-08-14 2004-02-12 Carsten Andersen Method for preparation of chewing gum with customer acceptable taste
GB2377633A (en) 2001-05-11 2003-01-22 Gw Pharmaceuticals Ltd Pharmaceutical compositions comprising the cannabinoids THC and CBD
GB2381194A (en) 2001-09-07 2003-04-30 Gw Pharmaceuticals Ltd Pharmaceutical formulations
US20020160043A1 (en) * 2001-02-27 2002-10-31 Dennis Coleman Compositions and method of manufacture for oral dissolvable dosage forms
FI20020333A0 (fi) * 2002-02-20 2002-02-20 Tomi Jaervinen Metyloidun syklodekstriinin uudet kompleksit
US7004174B2 (en) 2002-05-31 2006-02-28 Neothermia Corporation Electrosurgery with infiltration anesthesia
AU2003240824B9 (en) 2002-05-31 2008-09-25 University Of Mississippi Transmucosal delivery of cannabinoids
WO2004004479A1 (en) * 2002-07-02 2004-01-15 Gumlink A/S Compressed chewing gum
US6986907B2 (en) 2003-07-28 2006-01-17 Wm. Wrigley Jr. Company Chewing gum base and chewing gum compositions
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
GB2414933B (en) 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
GB0416861D0 (en) * 2004-07-29 2004-09-01 Quadrant Drug Delivery Ltd Composition
MX2007002336A (es) * 2004-08-25 2008-03-10 Cadbury Adams Usa Llc Composicion de goma de mascar con relleno liquido.
GB2432312A (en) 2005-11-01 2007-05-23 Gw Pharma Ltd Pharmaceutical compositions for the treatment of pain
US20100061940A1 (en) 2006-03-16 2010-03-11 Niconovum Ab Chewing Gum Compositions Providing Rapid Release of Nicotine
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US9308175B2 (en) 2006-09-15 2016-04-12 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
WO2008098195A2 (en) * 2007-02-09 2008-08-14 Todd Maibach Film comprising nitroglycerin
BRPI0910094B1 (pt) 2008-03-26 2021-08-10 Stichting Sanammad Composição de goma de mascar, e, blíster

Also Published As

Publication number Publication date
HUE044439T2 (hu) 2019-10-28
CA2719830A1 (en) 2009-10-01
EP2280687A1 (en) 2011-02-09
US20110097283A1 (en) 2011-04-28
BRPI0910094B1 (pt) 2021-08-10
PT2280687T (pt) 2019-06-04
CA2719830C (en) 2017-08-08
DK2280687T3 (da) 2019-05-27
US20150209322A1 (en) 2015-07-30
US9433601B2 (en) 2016-09-06
BRPI0910094A2 (pt) 2015-12-15
PL2280687T3 (pl) 2019-10-31
SI2280687T1 (sl) 2019-09-30
CA2719830F (en) 2009-10-01
HRP20190944T1 (hr) 2019-09-20
WO2009120080A1 (en) 2009-10-01
LT2280687T (lt) 2019-08-26
EP2280687B1 (en) 2019-02-27
US9023322B2 (en) 2015-05-05
TR201907776T4 (tr) 2019-06-21
ES2727648T3 (es) 2019-10-17

Similar Documents

Publication Publication Date Title
MX2010010607A (es) Composiciones para goma de mascar que comprenden canabinoides.
MX2010010508A (es) Composiciones de absorcion de sebo.
BR112012011583A2 (pt) composições bucais para tratamento de boca seca
WO2008085450A3 (en) Free-flowing filler composition and rubber composition containing same
TW200621313A (en) Pharmaceutical compositions
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX342107B (es) Composiciones de recubrimiento, composiciones de confiteria y goma de mascar y metodos.
MX2011012366A (es) Mezclas fungicidas sinergeticas.
MY158777A (en) Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
BR112013026802A2 (pt) estabilidade de peróxido melhorada em composições de tratamento oral
SG133531A1 (en) Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
BR112012032882A2 (pt) liberação aumentada de ingredientes lopofílicos de goma de mascar com hidrocoloides
WO2010122332A3 (en) Xanthan gum and swellable particulate containing composition and uses thereof
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
ATE523186T1 (de) Dentalzusammensetzungen mit wasserfänger
DK1971216T4 (da) Tyggegummi indeholdende styren-dien-blokcopolymerer
MX2010013254A (es) Composiciones nutritivas que contienen punicalaginas.
ATE533814T1 (de) Modifizierte olefinpolymere
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
MX2009008249A (es) Composicion farmaceutica que comprende derivado de camptotecina.
MX2010008668A (es) Composiciones fungicidas que comprenden 3'-bromo-2,3,4,6'-tetramet oxy-2'-6-dimetilbenzofenona.
MX2013002601A (es) Composiciones de goma de mascar que proporcionan perfiles de liberacion de sabor.
MX2011009364A (es) Composiciones de goma de mascar que proporcionan perfiles de liberacion de sabores.
HK1148544A1 (en) Coating compositions comprising a polymer containing an oligomeric macromonomer
MX2009003459A (es) Derivados de 2,3,3-trimetilciclopent-3-encarbaldehido utiles como odorantes.

Legal Events

Date Code Title Description
FG Grant or registration